Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment solutions remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherap